Resultados da busca - Troels M. Busk
- Mostrando 1 - 3 resultados de 3
-
1
Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double‐blind, placebo‐controlled trial por Nina Kimer, Julie Steen Pedersen, Troels M. Busk, Lise Lotte Gluud, Lise Hobolth, Aleksander Krag, Søren Møller, Flemming Bendtsen
Publicado em 2016Artigo -
2
Transjugular intrahepatic portosystemic shunt: impact on systemic hemodynamics and renal and cardiac function in patients with cirrhosis por Troels M. Busk, Flemming Bendtsen, Jørgen Poulsen, Jens Otto Clemmesen, Fin Stolze Larsen, Jens P. Goetze, Jens Iversen, Magnus T. Jensen, Rasmus Møgelvang, E. B. Pedersen, Jesper Nørgaard Bech, Søren Møller
Publicado em 2017Artigo -
3
Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trial por Nina Kimer, Julie Steen Pedersen, Juliette Tavenier, Jeffrey E. Christensen, Troels M. Busk, Lise Hobolth, Aleksander Krag, Waleed Abu Al‐Soud, Martin Steen Mortensen, Søren J. Sørensen, Søren Møller, Flemming Bendtsen
Publicado em 2017Artigo
Ferramentas de busca:
Assuntos relacionados
Cirrhosis
Internal medicine
Medicine
Antibiotics
Biology
Hemodynamics
Microbiology
Randomized controlled trial
Rifaximin
Alternative medicine
Bacterial translocation
Biochemistry
Cardiology
Chemistry
Chromosomal translocation
Double blind
Gastroenterology
Gene
Hepatology
Inflammation
Pathology
Placebo
Portal hypertension
Renal function
Shunt (medical)
Systemic circulation
Transjugular intrahepatic portosystemic shunt